Cytomegalovirus and long-term outcome after lung transplantation in Gothenburg, Sweden

References

• Alexander BD, Tapson VF. Infectious complications of lung transplantation. Transpl Infect Dis 2001;3:128–37.
   PubMedGoogle Scholar
• Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741–51.
   PubMed Web of Science ®Google Scholar
• Husni RN, Gordon SM, Longworth DL, Arroliga A, Stillwell PC, Avery RK, . Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998;26:753–5.
   PubMed Web of Science ®Google Scholar
• Duncan SR, Paradis IL, Yousem SA, Similo SL, Grgurich WF, Williams PA, . Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 1992;146:1419–25.
   PubMedGoogle Scholar
• Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM 3rd. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997;114:195–202.
   PubMed Web of Science ®Google Scholar
• Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, . Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297–310.
   PubMed Web of Science ®Google Scholar
• Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO, . Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report—2008. J Heart Lung Transplant 2008;27:957–69.
   PubMed Web of Science ®Google Scholar
• Bowdish ME, Arcasoy SM, Wilt JS, Conte JV, Davis RD, Garrity ER, . Surrogate markers and risk factors for chronic lung allograft dysfunction. Am J Transplant 2004;4:1171–8.
   PubMed Web of Science ®Google Scholar
• Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094–7.
   PubMed Web of Science ®Google Scholar
• Burton CM, Kristensen P, Lutzhoft R, Rasmussen M, Milman N, Carlsen J, . Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient– donor serotype matching. Scand J Infect Dis 2006;38:281–9.
   PubMed Web of Science ®Google Scholar
• Humar A, Kumar D, Preiksaitis J, Boivin G, Siegal D, Fenton J, . A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients. Am J Transplant 2005;5:1462–8.
   PubMed Web of Science ®Google Scholar
• Brumble LM, Milstone AP, Loyd JE, Ely EW, Pierson RN 3rd, Gautam S, . Prevention of cytomegalovirus infection and disease after lung transplantation: results using a unique regimen employing delayed ganciclovir. Chest 2002;121:407–14.
   PubMed Web of Science ®Google Scholar
• Zamora MR, Nicolls MR, Hodges TN, Marquesen J, Astor T, Grazia T, . Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Am J Transplant 2004;4:1635–42.
   PubMed Web of Science ®Google Scholar
• Palmer SM, Grinnan DC, Diane Reams B, Steele MP, Messier RH, Duane Davis R. Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir. Clin Transplant 2004;18:179–85.
   PubMed Web of Science ®Google Scholar
• Chmiel C, Speich R, Hofer M, Michel D, Mertens T, Weder W, . Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis 2008;46:831–9.
   PubMed Web of Science ®Google Scholar
• Valentine VG, Weill D, Gupta MR, Raper B, Laplace SG, Lombard GA, . Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation. J Heart Lung Transplant 2008;27:875–81.
   PubMed Web of Science ®Google Scholar
• Jaksch P, Zweytick B, Kerschner H, Hoda AM, Keplinger M, Lang G, . Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs. 12-month valganciclovir therapy. J Heart Lung Transplant 2009;28:670–5.
   PubMed Web of Science ®Google Scholar
• Russo MJ, Sternberg DI, Hong KN, Sorabella RA, Moskowitz AJ, Gelijns AC, . Postlung transplant survival is equivalent regardless of cytomegalovirus match status. Ann Thorac Surg 2007;84:1129–34; discussion 34–5.
   PubMed Web of Science ®Google Scholar
• Duncan SR, Grgurich WF, Iacono AT, Burckart GJ, Yousem SA, Paradis IL, . A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 1994;150:146–52.
   PubMed Web of Science ®Google Scholar
• Perreas KG, McNeil K, Charman S, Sharples LD, Wreghitt T, Wallwork J. Extended ganciclovir prophylaxis in lung transplantation. J Heart Lung Transplant 2005;24:583–7.
   PubMed Web of Science ®Google Scholar